Clinical Trial

Effects of Platelet-Rich Fibrin After Mandibular Third Molar Surgery in Smokers and Nonsmokers

Completed
View on ClinicalTrials.gov →
Summary
Mandibular third molar surgery is commonly associated with postoperative pain, swelling, and trismus. Platelet-rich fibrin (PRF) has been proposed as a biological adjunct to improve postoperative healing; however, its effectiveness in smokers remains unclear. This prospective randomized split-mouth clinical study aimed to evaluate the effects of PRF on postoperative pain, swelling, trismus, and analgesic consumption after impacted mandibular third molar surgery in smokers and nonsmokers. Thirty patients with bilaterally impacted mandibular third molars were included. PRF was placed in one extraction socket, while the contralateral socket served as the control site. Postoperative clinical outcomes were assessed during the first postoperative week and compared between smoking and nonsmoking patients.
Trial Details
NCT Number NCT07604584
Lead Sponsor Ankara University
Conditions Impacted Mandibular Third Molar, Postoperative Pain, Trismus, Facial Swelling
Enrollment 30 participants
Start Date 2017-05-15
Primary Completion 2018-12-21 (estimated)
Study Completion 2018-12-21 (estimated)
Updated on ClinicalTrials.gov 2026-05-22